Advanced Bladder Urothelial Carcinoma
2 clinical trials · Condition
◉ Watch Advanced Bladder Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study (NCT05092958) | National Cancer Institute (NCI) | 2022-06-03 |
| Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma (NCT03513952) | National Cancer Institute (NCI) | 2019-06-05 |
Track Advanced Bladder Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.